Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000696771 | SCV000825348 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-09-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000732666 | SCV000860643 | uncertain significance | not provided | 2018-04-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000732666 | SCV001803827 | likely benign | not provided | 2020-12-17 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002533462 | SCV003721590 | likely benign | Inborn genetic diseases | 2022-08-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |